Intra-Cellular Therapies Inc (23I.MU)
Munich - Munich Delayed price. Currency in EUR
Add to watchlist
As of 08:03AM CEST. Market open.
| Previous close | 61.00 |
| Open | 61.00 |
| Bid | 61.00 x N/A |
| Ask | 61.50 x N/A |
| Day's range | 61.00 - 61.00 |
| 52-week range | 44.00 - 72.00 |
| Volume | |
| Avg. volume | 7 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Simply Wall St.
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Intra-Cellular Therapies, Inc. ( NASDAQ:ITCI ) investors will be delighted, with the company turning in some strong...
- Insider Monkey
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript
Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Q1 2024 Earnings Call Transcript May 7, 2024 Intra-Cellular Therapies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, and welcome to Intra-Cellular Therapies’ First Quarter 2024 Earnings Conference Call. At […]
- GuruFocus.com
Intra-Cellular Therapies Inc (ITCI) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue ...
Explore key financial achievements and strategic directions from Intra-Cellular Therapies' first quarter of 2024, including a significant revenue increase and promising drug development updates.
© 2024 Yahoo. All rights reserved.